NASDAQ: CLBT
Cellebrite DI Ltd Stock

$18.90-0.13 (-0.68%)
Updated Apr 17, 2025
CLBT Price
$18.90
Fair Value Price
$5.61
Market Cap
$4.53B
52 Week Low
$10.25
52 Week High
$26.30
P/E
-14x
P/B
13.47x
P/S
11.5x
PEG
N/A
Dividend Yield
N/A
Revenue
$401.20M
Earnings
-$283.01M
Gross Margin
84.4%
Operating Margin
14.18%
Profit Margin
-70.5%
Debt to Equity
1.06
Operating Cash Flow
$132M
Beta
0.86
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CLBT Overview

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CLBT's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Software Infrastructure

Industry Rating
A
CLBT
Ranked
#18 of 125

Top Ranked Stocks in Industry

View Top Software Infrastructure Stocks

Be the first to know about important CLBT news, forecast changes, insider trades & much more!

CLBT News

Overview

Due Diligence Score

Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CLBT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLBT ($18.90) is overvalued by 237.07% relative to our estimate of its Fair Value price of $5.61 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CLBT ($18.90) is not significantly undervalued (237.07%) relative to our estimate of its Fair Value price of $5.61 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CLBT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CLBT due diligence checks available for Premium users.

Valuation

CLBT fair value

Fair Value of CLBT stock based on Discounted Cash Flow (DCF)

Price
$18.90
Fair Value
$5.61
Overvalued by
237.07%
CLBT ($18.90) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CLBT ($18.90) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CLBT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CLBT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-14x
Industry
-64.97x
Market
27.98x

CLBT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
13.47x
Industry
9.56x
CLBT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CLBT's financial health

Profit margin

Revenue
$109.0M
Net Income
$19.3M
Profit Margin
17.7%
CLBT's Earnings (EBIT) of $56.91M... subscribe to Premium to read more.
Interest Coverage Financials
CLBT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$690.6M
Liabilities
$354.5M
Debt to equity
1.06
CLBT's short-term assets ($567.59M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLBT's short-term assets ($567.59M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLBT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLBT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$66.0M
Investing
-$15.9M
Financing
$6.7M
CLBT's operating cash flow ($132.17M)... subscribe to Premium to read more.
Debt Coverage Financials

CLBT vs Software Infrastructure Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CLBTB$4.53B-0.68%-14.00x13.47x
VRNSC$4.55B-1.08%-46.97x9.98x
QLYSC$4.40B-0.60%25.56x9.22x
WEXC$4.78B+0.50%16.23x3.21x
BOXC$4.26B-0.44%21.18x-14.36x

Cellebrite DI Stock FAQ

What is Cellebrite DI's quote symbol?

(NASDAQ: CLBT) Cellebrite DI trades on the NASDAQ under the ticker symbol CLBT. Cellebrite DI stock quotes can also be displayed as NASDAQ: CLBT.

If you're new to stock investing, here's how to buy Cellebrite DI stock.

What is the 52 week high and low for Cellebrite DI (NASDAQ: CLBT)?

(NASDAQ: CLBT) Cellebrite DI's 52-week high was $26.30, and its 52-week low was $10.25. It is currently -28.14% from its 52-week high and 84.48% from its 52-week low.

How much is Cellebrite DI stock worth today?

(NASDAQ: CLBT) Cellebrite DI currently has 239,470,062 outstanding shares. With Cellebrite DI stock trading at $18.90 per share, the total value of Cellebrite DI stock (market capitalization) is $4.53B.

Cellebrite DI stock was originally listed at a price of $10.07 in Sep 11, 2020. If you had invested in Cellebrite DI stock at $10.07, your return over the last 4 years would have been 87.69%, for an annualized return of 17.05% (not including any dividends or dividend reinvestments).

How much is Cellebrite DI's stock price per share?

(NASDAQ: CLBT) Cellebrite DI stock price per share is $18.90 today (as of Apr 17, 2025).

What is Cellebrite DI's Market Cap?

(NASDAQ: CLBT) Cellebrite DI's market cap is $4.53B, as of Apr 21, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cellebrite DI's market cap is calculated by multiplying CLBT's current stock price of $18.90 by CLBT's total outstanding shares of 239,470,062.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.